Doctors Wary After Cholesterol Drug Flop

Courtesy Headlines from the Associated Press  Sun, 03/30/2008 - 11:26

CHICAGO (AP) -- Full results of a failed trial on Vytorin, a medicine taken by millions of Americans to lower cholesterol, left doctors stunned that the drug did not improve heart disease even though it worked as intended to lower three key risk factors....


 

More related items

FDA backs Vytorin for kidney disease patients
WASHINGTON (AP) -- The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential...

ACTHIV: HIV Boosts Risk of Heart Disease (CME/CE)
DENVER (MedPage Today) -- HIV increases the risk of coronary heart disease, independent of other risk factors, researchers reported here.

Control of Cardio Risk Factors Lags
(MedPage Today) -- Although U.S. adults have done a better job controlling hypertension and LDL cholesterol in recent years, most still are not treated to recommended targets, according to...

The Unwritten Rules of Friendship: Simple Strategies...
"Nobody likes me!" is a complaint that parents hear all too often, and few utterances make them feel more helpless. Now help is at hand: This practical and compassionate guidebook enables...

Burt's Bees Free Head to Toe Starter Kit


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com